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Purpose: To describe the results of cataract extraction with toric intraocular lens (IOL) 
implantation in patients with preexisting astigmatism from three corneal conditions (keratoconus, 
postkeratoplasty, and postpterygium surgery).
Methods: Cataract patients with topographically stable, fairly regular (although sometimes 
very high) corneal astigmatism underwent phacoemulsification with implantation of a toric 
IOL (Zeiss AT TORBI 709, Alcon Acrysof IQ toric SN6AT, AMO Tecnis ZCT). Postoperative 
astigmatism and refractive outcomes, as well as visual acuities, vector reduction, and complica-
tions were recorded for all eyes.
Results: This study evaluated 17 eyes of 16 patients with a mean age of 60 years at the time 
of surgery. Mean follow-up in this study was 12 months. The corrected distance Snellen visual 
acuity (with spectacles or contact lenses) 12 months postoperatively was 20/32 or better in 82% 
of eyes. The mean corneal astigmatism was 6.7 diopters (D) preoperatively, and 1.5 D of refrac-
tive cylinder at 1-year follow-up. No vision-compromising intra- or postoperative complications 
occurred and decentration or off-axis alignment of toric IOLs were not observed.
Conclusion: Phacoemulsification with toric IOL implantation was a safe and effective procedure 
in the three mentioned corneal conditions. Patient selection, counseling, and IOL placement 
with optimal astigmatism correction are crucial.
Keywords: toric intraocular lens, phacoemulsification, corneal astigmatism, keratoconus, 
postkeratoplasty, postpterygium surgery
Introduction
Toric intraocular lenses (IOLs) can be used at the time of cataract surgery to decrease 
postoperative astigmatism. Several studies have been published on toric lenses 
demonstrating significant reduction in spherical and astigmatic refractive errors 
with good efficacy, safety, and predictability in cataract patients.1,2 Additionally, in 
selected patients with corneal conditions, toric IOL implantation showed promising 
results.3–6
However, the safety and effectiveness of toric IOLs have not been fully substan-
tiated in patients with preexisting ocular conditions. Concerns still exist regarding 
potentially induced higher order aberrations due to complex coupling of the IOLs 
toricity with the corneal irregularity. Furthermore, irregular astigmatism seems to be 
a relative contraindication for toric IOL implantation.7
We performed this study to evaluate the visual and refractive outcomes of toric 
IOL implantation in cataract patients with topographically stable, although sometimes 
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very high, corneal astigmatism resulting from three corneal 
conditions (keratoconus, postkeratoplasty, and postpterygium 
surgery). Correcting the refractive error in these conditions 
is an off-label use of toric IOLs.
Materials and methods
In this retrospective study, patients were included who under-
went routine cataract surgery and toric IOL implantation 
between April 2011 and December 2013. All surgeries were 
performed by one surgeon (BVD) at the Amphia Hospital 
Breda, the Netherlands. Patients gave informed consent in this 
retrospective study for the implantation of a toric IOL. Accord-
ing to national regulations, obtaining institutional review board 
approval for conducting a retrospective study such as the pres-
ent study, is not mandatory. Patients were extensively informed 
and consented about the procedure (orally, with written infor-
mation as needed by the patient), before operation. Surgery 
was performed in accordance with the usual, high, clinical 
standards. Follow-up was performed at regular post-operative 
intervals and all relevant parameters were recorded.
Preoperatively, all patients underwent a complete oph-
thalmic evaluation including subjective refraction, Snellen 
best-corrected distance visual acuity (BCVA), applanation 
tonometry, slit-lamp examination, funduscopy, and corneal 
topography (type 70900, Pentacam HR, Oculus Optikgeräte 
GmbH, Wetzlar, Germany). Optical biometry was measured 
with the IOLMaster (Carl Zeiss Meditec AG, Jena, Germany) 
and if this was not possible due to the density of the cataract, 
it was measured by A scan ultrasonography (Nidek US-500, 
Gamagori, Japan). Endothelial cell counts were evaluated by 
confocal microscopy (Confoscan 4, Nidek, Padova, Italy) 
for all patients.
inclusion and exclusion criteria
Inclusion criteria for toric IOL implantation were visually 
significant cataract, fairly regular corneal astigmatism of 
1.25 D or more, a bow tie-like pattern on corneal topography 
and corneal-based astigmatism correctable with spectacles. 
Refraction had to be stable during multiple tomography 
examinations (total corneal refractive power map). Stable 
and nonprogressive astigmatism over a 6-month period 
was defined as no .1.00 D variation in the maximum 
topographic keratometry (K) value. After corneal surgery, 
this definition was used on the precondition of complete 
suture removal.
Exclusion cr i ter ia  included endothel ia l  cel l 
count ,1,500/mm2, irregular astigmatism unable to be cor-
rected with spectacles and ocular comorbidities that could 
have an impact on capsular bag stability, affect visual acuity, 
or the quality of vision. The severity of keratoconus was clas-
sified as mild, moderate, or severe according to the average 
K readings and based on the classification of Krumeich et al.8 
Patients with severe keratoconus (average K readings .55 D) 
were excluded from this study.
surgical technique
Surgery was performed using sub-Tenon’s anesthesia, 
except for one patient who preferred general anesthesia. 
Before the sub-Tenon’s block, the 3, 6, and 9 o’clock 
corneal markings were made with Nuijts–Lane Toric 
Reference Marker (AE-2791TBL, ASICO, Westmont, IL, 
USA) under topical anesthesia. Patients were instructed to 
sit upright and look forward to avoid supine cyclotorsion. 
Intraoperatively, the location of the corneal incision and 
axis of IOL placement was marked using Mendez degree 
gauge (AE-2765N, ASICO) and a Nuijts–Solomon Toric 
Axis Marker (AE-2740N, ASICO). A superotemporal near-
clear corneal incision was created in the keratoconus and 
postpterygium patients; corneoscleral incisions were made 
in postkeratoplasty patients. This was followed by injection 
of an ophthalmic viscosurgical device, capsulorhexis, pha-
coemulsification, bimanual irrigation/aspiration of cortical 
material, filling of the capsular bag with viscoelastic mate-
rial, toric IOL implantation and thorough irrigation and aspi-
ration, ensuring complete removal of residual viscoelastic 
behind the IOL as the standard procedure. During surgery, a 
dispersive ophthalmic viscosurgical device (hydroxypropyl 
methylcellulose 2%, Viscomet, Sun Pharmaceuticals Indus-
tries Ltd, Mumbai, India) was used to protect the endothe-
lium. The toric IOL was aligned with the corneal marks and 
a final check was made when the incisions were hydrated. 
Postoperatively, a standard regimen of topical nonsteroidal 
and steroid anti-inflammatory drops was used.
Toric iOls and power calculation
Toric IOLs were used from three different manufacturers: 
AT TORBI 709 (Carl Zeiss Meditec AG), Tecnis Toric ZCT 
IOL (Abbott Medical Optics, Inc, Santa Ana, CA, USA), 
and Acrysof SN6AT toric IOL (Alcon Laboratories, Inc., 
Fort Worth, TX, USA). All the three types are single-piece 
toric IOLs. Because of its cylinder power range (+12.00 D 
to +1.00 D), Zeiss AT TORBI 709 was used for cataract 
patients with high amounts of corneal astigmatism. In the 
beginning, Acrysof SN6AT was placed in cataract patients 
with moderate amounts of astigmatism because it was the 
most readily available toric IOL. In the later years, AMO 
Tecnis ZCT toric IOL became our standard IOL for cataract 
patients with moderate astigmatism.
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Patient assessment and postoperative 
follow-up
Preoperative biometry and topographic keratometry, the 
expected amount of surgically induced astigmatism, and the 
site of incision were used to determine the appropriate toric IOL 
model, alignment axis, and spherical equivalent (SE) power. 
The Haigis formula was used as the main method for spheri-
cal IOL power calculation and compared with the SRK/T, 
Hoffer-Q, and Holladay 1 formulas.9–13 Toric IOL power cal-
culation and orientation placement were performed using the 
software provided by the manufacturer of the IOLs.14–16
analysis
Patients were seen 1 day, 1 week, and 1, 3, 6, and 12 months after 
cataract surgery whenever possible. All eyes were examined 
at each postoperative visit, including visual acuity, refraction, 
applanation tonometry, and slit-lamp examination. Postopera-
tively, the orientation axis of the toric IOL was determined by 
using the biomicroscope and full mydriasis of the pupil.
Visual outcomes are presented in the form of BCVA with 
spectacles or contact lenses. Refractive data are provided 
in the form of sphere, positive cylinder, and cylinder axis. 
For analysis purposes, visual acuities were converted from 
Snellen acuity to logMAR.17
Based on the results, we calculated the safety index (ratio 
of postoperative BCVA over preoperative BCVA). The effi-
cacy index (ratio of postoperative uncorrected visual acuity 
over preoperative BCVA) could not be examined due to lack 
of standardized postoperative uncorrected visual acuity data 
in this retrospective study.
A full description of refractive error was done with the 
three-dimensional vector that takes into account magnitude 
and axis of astigmatism as well as the spherical component. 
Therefore, spherocylindrical refraction results (S [sphere], 
C [cylinder], α [axis]) were converted to power vector coor-
dinates M, J
0
, and J
45
 by the following formulas:
 M = S + C/2 (1)
 J
0 
= (−C/2)*cos (2α) (2)
 J
45 
= (−C/2)*sin (2α), (3)
where M is equal to the SE of the given refractive error; J
0
 is 
the Jackson cross-cylinder, axes at 90° and 180°; J
45
 is the 
Jackson cross-cylinder, axes at 45° and 135°.18–20
Results
We retrospectively studied 17 eyes of 16 patients, four 
(25%) females and 12 (75%) males. Mean patient age at 
the time of surgery was 60±11 years. Table 1 shows the 
demographic data prior to surgery, types, and parameters of 
implanted lenses. The AMO ZCT toric IOL was implanted in 
six patients (six eyes), Zeiss AT TORBI 709 in four patients 
(five eyes), and six patients (six eyes) received the Alcon 
Acrysof IQ toric SN6AT toric IOL.
Complications
No vision-compromising intraoperative complications 
occurred. One patient suffered from postoperative macula-on 
retinal detachment, which could be surgically repaired 
without loss of vision. Decentration or off-axis alignment of 
the toric IOL was not observed, and no graft had rejection 
episodes.
Visual acuity
Visual outcomes are presented in BCVA (or contact lens 
visual acuity in one patient). Figure 1 shows the BCVA 
Table 1 Baseline parameters
Patients (n) 6 7 3
eyes (n) 6 8 3
age (years) 59±9 54±8 74±6
refractive sphere (D) −7.4±3.0 −6.0±4.7 −0.5±0.7
refractive cylinder (D) 4.0±1.8 5.5±3.4 4.7±1.6
refractive se (D) −5.4±2.4 −3.3±3.9 1.8±0.3
Corneal astigmatism (D)* 6.1±5.9 7.3±4.3 3.9±0.4
iOl sphere (D) 6.7±8.3 10.2±10.3 21.3±1.0
iOl cylinder (D) 5.8±3.0 7.3±4.3 4.4±0.6
iOl se (D) 9.6±6.9 13.8±9.1 23.5±1.2
aT TOrBi 709, Carl Zeiss (n) 1 4 0
Tecnis Toric ZCT iOl abbott (n) 2 2 2
acrysof sn6aT alcon (n) 3 2 1
Notes: Data are expressed as mean ± sD. *Pentacam-derived (simK).
Abbreviations: iOl, intraocular lens; sD, standard deviation; se, spherical equivalent.
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Figure 1 Preoperative versus 12-month postoperative BCVa.
Abbreviation: BCVa, best-corrected visual acuity.
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before toric IOL implantation and after a mean follow-up 
period of 12 months postoperatively. The mean BCVA was 
0.59±0.44 logMAR preoperative and 0.13±0.13 logMAR 
1 year postoperative. The corrected distance Snellen visual 
acuity 12 months postoperatively was 20/32 (0.6) or better in 
14 eyes (82%) and 20/25 (0.8) or better in ten eyes (59%).
refraction
The mean refractive SE decreased from −3.10±3.95 D 
preoperatively to 0.22±1.53 D postoperatively.
safety
The safety results for toric IOL implantation are presented 
in Figure 2. There was loss of one line in one patient, likely 
due to a macular pucker with metamorphopsia. All other 
eyes gained two lines or more. The mean safety index was 
4.88±8.02.
Predictability
Figure 3 shows the distribution of manifest preoperative 
corneal astigmatism and the refractive cylinder at a mean 
of 12 months postsurgery. The mean refractive cylinder 
decreased from 6.3±4.7 D preoperatively to 1.5±1.5 D at 
1 year after toric IOL implantation.
Vector analysis
Figure 4 shows the scatter plot of the astigmatic vectors 
(J
0
, J
45
) before and after toric IOL implantation. The more 
central location of postoperative data around 0 represents the 
reduction of preoperative astigmatism by the implantation 
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Figure 2 Changes in BCVa (snellen chart) after 12 months of toric intraocular 
lens implantation.
Note: *Comorbidity: macular pucker with metamorphopsia (postoperative 
BCVa 0.6).
Abbreviation: BCVa, best-corrected visual acuity.








 ±

±

±

±

±

±
 !
1XP
EHU
RIH
\HV
Q
&\OLQGHU'
3RVWRSHUDWLYH3UHRSHUDWLYH
Figure 3 Preoperative corneal astigmatism versus 12-month postoperative 
refractive cylinder distribution in diopters (D).
of the toric implantable IOL. The value (0,0) represents an 
eye free of astigmatism. Mean M dropped from 3.1±3.9 to 
0.1±1.5. J
0
 dropped from 0.9±0.9 to −0.1±0.3. J
45
 changed 
from 0.7±0.6 to −0.1±0.5.
Patient satisfaction
Overall, patient satisfaction was fairly good for most patients. 
Although phacoemulsification and toric IOLs implantation 
did not provide total refractive correction, most patients 
were pleased with the improvement they experienced. In our 
group of patients, slight residual refraction error was well 
tolerated and wearing spectacles or contact lenses usually 
was not a problem. Two patients were less satisfied because 
of comorbidity from a macular pucker (n=1) and the addi-
tional need for a scleral contact lens because of the residual 
anisometropia (n=1). By using the scleral contact lens, the 
patient achieved a postoperative BCVA of 20/30 (0.7).
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Figure 4 scatter plot of the astigmatic vectors (J0 and J45) before and after toric 
intraocular lens implantation.
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Initially, one patient was less satisfied because of the 
conversion from myopia to slight hypermetropia (SE + 1.0 D, 
target was emmetropia). This patient went back to isometro-
pia after cataract surgery of the other eye and was happy 
wearing multifocal spectacles.
Discussion
In our series, phacoemulsification with toric IOL implanta-
tion for visually significant cataract was a safe and effective 
procedure in the three corneal conditions (keratoconus, post-
keratoplasty, and postpterygium surgery). Our results are in 
agreement with previously published case reports and series 
on toric IOL implantation for correcting postkeratoplasty 
astigmatism and keratoconus in cataract patients.3,6,21–27
To our knowledge, no previous studies reported the 
outcomes of toric IOL implantation in patients having 
phacoemulsification after previous pterygium surgery. 
Furthermore, most of the available literature reports results 
from only the Acrysof toric IOL since this is one of the most 
commonly used toric IOL in cataract surgery. We, however, 
were able to show the safety and effectiveness of toric IOLs 
from three different manufacturers.
In our series, one male patient suffered from macula-on 
retinal detachment about 5 weeks postoperatively. Fortu-
nately, the detachment was recognized early and repaired 
before loss of vision occurred. This complication was one 
typically associated with cataract surgery and high myopia.28 
Our myopic keratoconus patient had an axial length of 27.99 
mm and therefore was prone to retinal detachment.
In this study, toric IOL implantation was only considered 
in patients with stable corneal pathology and fairly regular 
astigmatism. Extensive preoperative corneal topography, 
including total corneal power analysis and several con-
secutive examinations over a longer time period, is crucial. 
If endothelial graft failure should occur, the existing refrac-
tive situation after insertion of a toric IOL may be maintained 
by proceeding with endothelial keratoplasty.
For patients who wish to continue to wear a contact lens 
after surgery, there is uncertainty as to the optimum target for 
postoperative refraction for optimal postoperative contact lens 
fit. If a patient wants to return to a rigid (bi)toric or scleral 
contact lens after toric IOL implantation, the astigmatism of 
the IOL will become manifest. A bitoric rigid gas permeable 
design may then be necessary. Alternatively, the toric IOL may 
be exchanged for a spherical IOL design.29 Therefore, it should 
be emphasized that toric IOL implantation is a suitable option 
only in patients with astigmatism who can be satisfactorily 
corrected with spectacles and have realistic expectations.
In most cases, the treatment provided was not expected to 
fully correct the patient’s eyesight to emmetropia. It is advis-
able to remain on the conservative (myopic) side with choice 
of target SE. Slight residual astigmatism may also be benefi-
cial because of increased depth of focus. Our patients were 
counseled regarding the limitations of the toric IOL in fully 
correcting the astigmatism. The operating surgeon should 
be aware of the tendency toward hyperopic outcomes in 
any cataract surgery in steep keratoconic corneas. Biometry 
in eyes with severe keratoconus will typically overestimate 
the corneal power and underestimate the IOL power, with 
a tendency to postoperative hyperopic biometry prediction 
error.8,30 Therefore, we only included patients with mild and 
moderate amounts of keratoconus.
It is not surprising that, in the present study, there was 
a large reduction in the mean refractive SE. The decrease 
in the magnitude of astigmatism reflects that the toric 
IOLs effectively addressed that component. The decrease 
from −3.10±3.95 D preoperatively to a postoperative SE of 
0.22±1.53 D reflects successful reduction in astigmatism with 
some cases of mild overcorrection. This stresses the impor-
tance of a myopic target with the postoperative hyperopic 
prediction error as described earlier.
The technique we used to mark the axis of IOL align-
ment preoperatively and confirm alignment by using the 
biomicroscope postoperatively is not flawless. However, 
we did not find significant rotational misalignment at last 
follow-up, which is in agreement with previously published 
reports showing good rotational stability for the three types 
of toric IOLs.2,31–33
Mean safety index was 4.88±8.02. When analyzing this 
high value, especially the amount of standard deviation, it is 
important to take into account the fact that the improvement in 
BCVA derives not only from the correction of refractive astig-
matism, but also from the removal of cataract. The BCVA of 
one patient increased from distinguishing hand movements at 
a distance of 10 feet to a postoperative BCVA of 20/63. Due 
to this specific case, the standard deviation increased.
Our vector analysis was based on the three-dimensional 
vector that takes into account magnitude and axis of astig-
matism, as well as the spherical component. Because astig-
matism analysis is multidimensional, it is not possible to 
capture the nuances in a single graphical display. There are 
other, possibly superior, methods of reporting on the manifest 
refractive astigmatism before and after a procedure. Given 
the complexity of analyzing astigmatism, there are inevitable 
differences between these approaches; so far, absolute agree-
ment on a standard has not been reached.34
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We acknowledge that there are limitations to this ret-
rospective study. There is a degree of heterogeneity in our 
cohort of patients and the cohort is small, which makes basic 
statistical comparison inappropriate. However, we believe 
that we were able to show meaningful long-term visual and 
refractive results with overall good patient satisfaction. As 
always, careful patient selection and thorough and complete 
patient information are paramount.
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